ABSTRACT
The research on quality control of Chinese materia medica (CMM) has always been the key to the research and development of CMM. The quality standard of CMM determines the safety and effectiveness of CMM. As the effective ingredients of CMM, pharmacological material base is not clear, making it difficult to internationalization of traditional Chinese medicine. Faced with this problem, modern pharmacy research has made a lot of remarkable results. The determination of intrinsic components by high performance liquid chromatography, gas chromatography and so on, from single index to multi-index, combined with fingerprints and pharmacological effects of research have made a lot of progress. Quality markers of the new concept of the proposed quality standards for CMM put forward new requirements, is conducive to the establishment of quality control and quality traceability system of CMM, which brings new hope for the development of CMM industry.
ABSTRACT
Hyperlipidemia is a common clinical disease. In recent years, the incidence of hyperlipidemia increased, and patients gradually increased. Hyperlipidemia easily leads to atherosclerosis, coronary heart disease and other cardiovascular and cerebrovascular diseases, and causes crisis to human health. Clinically, Western medicine treatment has a good effect, but also the existence of side effects and even toxic effects, long-term use of drug resistance and other issues. Chinese materia medica (CMM) under the guidance of traditional Chinese medicine theory, with good efficacy and side effects of small features in the clinical dialectical treatment, plays the characteristics of Chinese medicine, and has obvious advantages. In this paper, CMM monomer, single CMM, compound, and integrated traditional Chinese and Western medicine in the treatment of hyperlipidemia were reviewed, and Chinese medicine lipid-lowering development prospects and problems were analyzed.